Elicio Therapeutics (ELTX) Misses Q1 EPS by 65c

Elicio Therapeutics (NASDAQ: ELTX) reported Q1 EPS of ($0.65).

For earnings history and earnings-related data on Elicio Therapeutics (ELTX) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• Independence Realty Trust (IRT) files mixed shelf
• Lockheed Martin wins $2.8B in Defense contracts for F-35, helicopters